Wisbiom
Pioneering the future of human health with innovative microecological preparations and living biopharmaceuticals.
Pioneering the future of human health with innovative microecological preparations and living biopharmaceuticals.
Wisbiom is a pioneering microbiotherapy company that was founded in 2017. Specializing in Biopharma and Biotechnology, it is dedicated to developing innovative microecological preparations, living biopharmaceuticals (LBP), and microbiome-related products. The company recently secured a significant $1.40M in Seed Round investment on 18 December 2023, with funding from notable investors including Hengxu Capital, ELIM Capital, Sinofaith intellectual Property, and Xiu Xiu Group. Wisbiom's mission is to revolutionize human health through cutting-edge advancements in microecology, positioning itself at the forefront of the future of healthcare.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | $1.40M | 4 |
|
18 Dec 2023 |
No recent news or press coverage available for Wisbiom.
We care about your data, and we'd love to use cookies make your experience better.
